FRCPC MD - VBI Vaccines Chief Officer
| VBIVQ Stock | 0.0005 0.0001 16.67% |
Executive
FRCPC MD is Chief Officer of VBI Vaccines
| Age | 69 |
| Address | 160 Second Street, Cambridge, MA, United States, 02142 |
| Phone | 617 830 3031 |
| Web | https://www.vbivaccines.com |
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Kathryn Roark | Patterson UTI Energy | N/A | |
| Nicolas Lorenz | Westrock Coffee | N/A | |
| Lexington May | Transocean | N/A | |
| Robert McKinney | Westrock Coffee | 60 | |
| Brady JD | Transocean | 51 | |
| Roddie Mackenzie | Transocean | N/A | |
| Ian Wilson | Awilco Drilling PLC | 56 | |
| Michael Sabella | Patterson UTI Energy | N/A | |
| Kyle Jones | Westrock Coffee | N/A | |
| Matt Pye | Patterson UTI Energy | N/A | |
| Arthur DElia | Dominos Pizza | 46 | |
| Kate Trumbull | Dominos Pizza | N/A | |
| Robert JD | Westrock Coffee | 60 | |
| Gregory Lemenchick | Dominos Pizza | N/A | |
| Cathrine Haavind | Awilco Drilling PLC | N/A | |
| Kenneth Pucheu | Patterson UTI Energy | 46 | |
| Kenneth CPA | Patterson UTI Energy | 64 | |
| Paul Johnson | Transocean | N/A | |
| Roddy Smith | Awilco Drilling PLC | 51 | |
| B Mgt | Transocean | 49 | |
| Peter Sadowski | Cannae Holdings | 69 | |
VBI Vaccines Leadership Team
Elected by the shareholders, the VBI Vaccines' board of directors comprises two types of representatives: VBI Vaccines inside directors who are chosen from within the company, and outside directors, selected externally and held independent of VBI. The board's role is to monitor VBI Vaccines' management team and ensure that shareholders' interests are well served. VBI Vaccines' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, VBI Vaccines' outside directors are responsible for providing unbiased perspectives on the board's policies.
| FRCPC MD, Chief Officer | ||
| Nicole Anderson, Director Relations | ||
| Avi Mazaltov, Global SciVac | ||
| Misha Nossov, Senior Europe | ||
| David Anderson, Chief Officer | ||
| Jeffery FCMA, CEO President | ||
| Nell Beattie, Head CFO | ||
| Athena Kartsaklis, Chief Finance | ||
| John Dillman, Chief Officer |
VBI Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is VBI Vaccines a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Revenue | 8.68 M | ||||
| Net Income | (92.84 M) | ||||
| Total Debt | 50.77 M | ||||
| Cash Flow From Operations | (60.88 M) | ||||
| Number Of Employees | 131 | ||||
| Total Asset | 86.95 M | ||||
| Retained Earnings | (582.45 M) | ||||
| Working Capital | (39.51 M) | ||||
| Net Asset | 86.95 M |
Pair Trading with VBI Vaccines
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if VBI Vaccines position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VBI Vaccines will appreciate offsetting losses from the drop in the long position's value.Moving together with VBI Stock
Moving against VBI Stock
| 0.53 | EPRX | Eupraxia Pharmaceuticals | PairCorr |
| 0.48 | GRCE | Grace Therapeutics, Symbol Change | PairCorr |
| 0.44 | FBIOP | Fortress Biotech Pref | PairCorr |
| 0.39 | FRTX | Fresh Tracks Therapeutics | PairCorr |
| 0.37 | UPB | Upstream Bio, | PairCorr |
The ability to find closely correlated positions to VBI Vaccines could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace VBI Vaccines when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back VBI Vaccines - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling VBI Vaccines to buy it.
The correlation of VBI Vaccines is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as VBI Vaccines moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if VBI Vaccines moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for VBI Vaccines can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for VBI Stock Analysis
When running VBI Vaccines' price analysis, check to measure VBI Vaccines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VBI Vaccines is operating at the current time. Most of VBI Vaccines' value examination focuses on studying past and present price action to predict the probability of VBI Vaccines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VBI Vaccines' price. Additionally, you may evaluate how the addition of VBI Vaccines to your portfolios can decrease your overall portfolio volatility.